Strain-level characterisation and visualisation of the mucosal microbial communities associated with Inflammatory Bowel Disease (IBD) for the development of novel biotherapeutics [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Australia has one of the highest incidence rates in the world of Inflammatory Bowel Disease (IBD), a debilitating inflammatory condition of the gastrointestinal tract. Cutting-edge molecular and visualisation technologies will be used to examine the role of the gut microbiome in IBD, and identify specific members of this community to be used as new therapies to suppress inflammation and improve outcomes for patients with IBD.

Funding Amount $1,181,878

Funding Scheme Ideas Grants

Chief Investigator Prof Gene Tyson

Notes Ideas Grants